← FDA Drug Approvals (Drugs@FDA)
LOMUSTINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CARNEGIE · Approved 2025-10-27
Drug application
- FDA Application #
ANDA219265- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LOMUSTINE
- Generic name
- LOMUSTINE
- Active ingredients
- LOMUSTINE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CARNEGIE
- Manufacturer
- Carnegie Pharmaceuticals LLC
- First approval
- 2025-10-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown